TXNIP contributes to HIV-1 transcriptional competence and inducible reactivation through an EZH2-ETV1 regulatory pathway
PLOS Pathogens · 16.11.2026 · 22 (11) · e1014748
DOI: 10.1371/journal.ppat.1014748 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 16.11.2026. Verfasst von Ziyao Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of New Drug Screening, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, NMPA…. Hauptthemen laut MEDLINE: HIV-1, Enhancer of Zeste Homolog 2 Protein, Carrier Proteins, Transcription Factors. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Major Science and Technology Projects of China, Innovative Research Group Project of the National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Persistent human immunodeficiency virus type 1 (HIV-1) latency remains a major barrier to durable remission, yet the host pathways that regulate proviral transcriptional competence and inducible reactivation remain incompletely defined. Thioredoxin-interacting protein (TXNIP) is a glucose-responsive host factor, but its role in HIV-1 transcription and latency regulation has not been established. Here, we provide evidence that TXNIP supports HIV-1 long terminal repeat (LTR)-driven transcription, productive replication, and latency reversal. Genetic depletion of TXNIP reduced LTR reporter activity, nascent viral transcripts, virus production, and latency-reversing agent (LRA)-induced reactivation across reporter-based, productive-infection, chronically infected, latency, primary-cell, and ex vivo models, whereas TXNIP overexpression enhanced viral transcriptional output. Chromatin immunoprecipitation (ChIP) further detected TXNIP-associated signals at HIV-1 LTR-containing chromatin in both TZM-bl and Jurkat T-cell contexts, and co-immunoprecipitation (Co-IP) analyses showed that TXNIP associates with BRD4-, CDK9-, and Tat-containing transcriptional complexes, consistent with a cofactor-associated model of TXNIP-linked HIV-1 transcriptional regulation. Mechanistically, our data support an enhancer of zeste homolog 2 (EZH2)-ETS variant transcription factor 1 (ETV1)-TXNIP regulatory axis linking epigenetic repression to HIV-1 transcriptional control. Genetic EZH2 perturbation and pharmacological perturbation of EZH2-associated repression reduced histone H3 lysine 27 trimethylation (H3K27me3) enrichment at the ETV1 promoter, increased ETV1 expression, and enhanced TXNIP promoter activity. ChIP-qPCR and promoter-reporter analyses supported an ETV1-associated regulatory link between EZH2-associated repression and TXNIP expression. Pharmacological perturbation with SRI-37330 suppressed HIV-1 replication, nascent transcription, and inducible reactivation, including in ex vivo CD4 + T cells from antiretroviral therapy (ART)-suppressed individuals; this inhibitory effect was attenuated in TXNIP-depleted cells. Together, these findings identify TXNIP as a host determinant of HIV-1 transcriptional competence and support an EZH2-ETV1-TXNIP regulatory pathway that links epigenetic regulation of TXNIP expression to HIV-1 transcriptional control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of New Drug Screening, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School…
- Translational Medicine Center of Jiangxi University of Chinese Medicine, Nanchang, People's Republic of China.
- Guangzhou National Laboratory, Guangzhou International Bio-Island, Guangzhou, People's Republic of China.
- State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, People's Repu…
- College of Pharmacy, Nanchang Medical College, Nanchang, People's Republic of China.
ORCID-Profile: Shuwen Liu, Lin Li
Förderung
- National Major Science and Technology Projects of China
- Innovative Research Group Project of the National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wu, Z., Zhang, H., Liang, T., Zhang, Y., Xia, M., Zhou, C., Li, Y., Peng, J., Liu, S., & Li, L. (2026). TXNIP contributes to HIV-1 transcriptional competence and inducible reactivation through an EZH2-ETV1 regulatory pathway. PLOS Pathogens, 22(11), e1014748. https://doi.org/10.1371/journal.ppat.1014748
Vancouver
Wu Z, Zhang H, Liang T, Zhang Y, Xia M, Zhou C, et al. TXNIP contributes to HIV-1 transcriptional competence and inducible reactivation through an EZH2-ETV1 regulatory pathway. PLOS Pathogens. 2026;22(11):e1014748. doi:10.1371/journal.ppat.1014748
BibTeX
@article{Wu2026,
author = {Wu, Ziyao and Zhang, Han and Liang, Taizhen and Zhang, Yuzai and Xia, Muye and Zhou, Chenliang and Li, Yibin and Peng, Jie and Liu, Shuwen and Li, Lin},
title = {TXNIP contributes to HIV-1 transcriptional competence and inducible reactivation through an EZH2-ETV1 regulatory pathway},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {11},
pages = {e1014748},
doi = {10.1371/journal.ppat.1014748}
}
EUVIMED